Response to: 'Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus' by Rua-Figueroa and Erausquin

Antonis Fanouriakis¹, George Bertsias^{2

3}, Dimitrios T Boumpas^{4

5

6}

Affiliations

¹ Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece.
² Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece.
³ Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece.
⁴ Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece boumpasd@uoc.gr.
⁵ Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
⁶ Joint Academic Rheumatology Program, Medical School, National and Kapodestrian University of Athens, Athens, Greece.

Comment

Antonis Fanouriakis et al. Ann Rheum Dis. 2020 Oct.

. 2020 Oct;79(10):e132.

doi: 10.1136/annrheumdis-2019-215810. Epub 2019 Jul 3.

Antonis Fanouriakis¹, George Bertsias^{2

3}, Dimitrios T Boumpas^{4

5

6}

¹ Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece.
² Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece.
³ Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece.
⁴ Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece boumpasd@uoc.gr.
⁵ Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
⁶ Joint Academic Rheumatology Program, Medical School, National and Kapodestrian University of Athens, Athens, Greece.

No abstract available

Keywords: disease activity; systemic lupus erythematosus; treatment.

Conflict of interest statement

Competing interests: None declared.

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT. Fanouriakis A, et al. Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29. Ann Rheum Dis. 2019. PMID: 30926722
Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Rua Figueroa Í, Erausquin C. Rua Figueroa Í, et al. Ann Rheum Dis. 2020 Oct;79(10):e131. doi: 10.1136/annrheumdis-2019-215778. Epub 2019 Jun 5. Ann Rheum Dis. 2020. PMID: 31167760 No abstract available.